Tirzepatide Weight Loss in Phoenix

Physician supervised tirzepatide programs for adults wanting strong weight loss support. Hospital grade medication, dual receptor action, and personalized monitoring.

What Is Tirzepatide?

Tirzepatide is a dual agonist medication that activates both GLP 1 and GIP receptor pathways. It is the active ingredient in the FDA approved medications Mounjaro (for type 2 diabetes) and Zepbound (for weight loss). Tirzepatide is newer than semaglutide but has shown stronger weight loss results in head to head clinical trials.


GLP 1 is the same hormone pathway semaglutide works on. GIP (glucose dependent insulinotropic polypeptide) is another hormone involved in insulin response and metabolism. By activating both pathways, tirzepatide may produce more comprehensive effects on appetite, metabolism, and blood sugar than single agonist medications.


At The Good Life IV, tirzepatide is provided as a prescription medication under physician supervision. Our Medical Director reviews your health history and goals during your consultation. We source tirzepatide from licensed compounding pharmacies that meet United States Pharmacopeia standards.

How Tirzepatide Works

Tirzepatide works on two hormone pathways at the same time. The GLP 1 effects are similar to semaglutide: reduced hunger, slower stomach emptying, and improved blood sugar regulation. The GIP effects add an additional layer of metabolic support that may enhance the weight loss response.



The combination of these two pathways may explain why clinical trials have shown tirzepatide produces more average weight loss than semaglutide. People on tirzepatide often report stronger appetite suppression and faster initial weight loss compared to semaglutide.


Tirzepatide is given as a weekly subcutaneous injection. Dosing starts at 2.5 mg per week and titrates up gradually based on response and tolerance. Most protocols increase every 4 to 8 weeks until reaching the effective dose for your goals.

Key Benefits of Tirzepatide

  • Strong Average Weight Loss

    Clinical trials have shown tirzepatide produces average weight loss of 15 to 22 percent of body weight, higher than semaglutide on average.

  • Dual Receptor Action

    By activating both GLP 1 and GIP receptors, tirzepatide may provide more comprehensive metabolic effects than single agonist medications.

  • Significant Reduction in Food Noise

    Many tirzepatide users report dramatic reductions in food cravings and constant thoughts about food, often more so than with semaglutide.

  • Supports Blood Sugar Regulation

    Like semaglutide, tirzepatide supports healthy blood sugar regulation, benefiting adults with prediabetes or type 2 diabetes.

  • Weekly Dosing

    Tirzepatide is taken once per week, which is more convenient than daily medications.

  • FDA Approved for Weight Loss

    The FDA approved version of tirzepatide (Zepbound) is specifically approved for chronic weight management.

Who Is Tirzepatide For?

Tirzepatide is most commonly used by adults wanting stronger weight loss support than single agonist medications. It may be a good fit if you fall into any of these categories.


  • Adults with a BMI of 27 or higher
  • People who have tried semaglutide without enough results
  • Adults wanting the strongest current GLP 1 class option (excluding retatrutide)
  • People with prediabetes or type 2 diabetes
  • Adults focused on significant body composition changes
  • People who want physician supervision and accountability

Who Should Not Use Tirzepatide

Tirzepatide is not appropriate for everyone. People in these categories should not use tirzepatide.


  • People with a personal or family history of medullary thyroid carcinoma
  • People with multiple endocrine neoplasia syndrome type 2
  • Pregnant or nursing women
  • People with severe gastrointestinal disease
  • Anyone with active eating disorders without specialist clearance
  • Children and adolescents under 18


Our Medical Director reviews your full health history during your consultation.

How Our Program Works

Every medical weight loss protocol starts with a consultation and Good Faith Exam with our Medical Director, Dr. Decker Weiss, NMD, FASA. We use medications from licensed compounding pharmacies that meet United States Pharmacopeia standards. Baseline lab work is typically required. Dosing starts low and titrates up. Follow ups are scheduled regularly to monitor progress and adjust as needed.

What to Expect

Timeline

Most people notice reduced hunger and food noise within the first 1 to 2 weeks. Initial weight loss typically begins by week 2 to 4. Clinical trials show steady weight loss over 18 months with proper titration. Average 15 to 22 percent body weight loss over 72 weeks of treatment.


Common Experiences

Tirzepatide users often report dramatic changes in their relationship with food. Many describe feeling indifferent to foods that used to drive cravings. Portion sizes naturally shrink. Some people experience stronger nausea than with semaglutide during titration, which usually improves over time.


Side Effects

Common tirzepatide side effects include nausea (especially during dose increases), constipation, diarrhea, fatigue, and occasional vomiting. Most side effects improve as your body adjusts. Less common but serious side effects can include pancreatitis, gallbladder problems, and rare thyroid concerns. Our Medical Director provides full disclosure.

Tirzepatide Pricing

Compounded tirzepatide typically costs $400 to $600 per month including the medication and physician monitoring. Brand name Zepbound is more expensive and may be partially covered by some insurance plans.

Frequently Asked Questions About Tirzepatide

  • Is tirzepatide better than semaglutide?

    Clinical trials show tirzepatide produces higher average weight loss than semaglutide. However, individual responses vary. Some people respond better to semaglutide. Your Medical Director can help you decide which is right for you.

  • Is tirzepatide the same as Mounjaro?

    Mounjaro is the brand name for tirzepatide approved for type 2 diabetes. Zepbound is the brand name approved for weight loss. Compounded tirzepatide is the same active ingredient prepared by a licensed compounding pharmacy.

  • How much weight will I lose on tirzepatide?

    Clinical trials show average weight loss of 15 to 22 percent of body weight over 72 weeks. Individual results vary.

  • How is tirzepatide different from semaglutide?

    Semaglutide activates only GLP 1 receptors. Tirzepatide activates both GLP 1 and GIP receptors. The dual action may produce stronger metabolic effects.

  • Is tirzepatide safe?

    Tirzepatide has been used in medical practice for several years with a good safety profile under physician supervision. Like all medications, it requires monitoring and proper dosing.

  • Can I switch from semaglutide to tirzepatide?

    Yes. Many adults switch from semaglutide to tirzepatide if they want stronger results. Your Medical Director will guide you through the transition.

  • Will insurance cover tirzepatide?

    Brand name Zepbound may be partially covered by some insurance plans for qualifying patients. Compounded tirzepatide is typically not covered. Some HSA and FSA accounts may apply.

  • What happens if I stop tirzepatide?

    Most people regain some or all of the weight they lost if they stop tirzepatide without significant lifestyle changes. Some adults transition to maintenance dosing rather than stopping entirely.

Start Tirzepatide in Phoenix

Tirzepatide may be a useful tool in your weight loss journey. Book a consultation with our Medical Director to find out if it is right for you.